James Loy
Bristol-Myers Squibb (United States)(US)Bioanalytica (Switzerland)(CH)
Publications by Year
Research Areas
Immune Cell Function and Interaction, Hepatitis C virus research, Monoclonal and Polyclonal Antibodies Research, Cytokine Signaling Pathways and Interactions, HIV/AIDS drug development and treatment
Most-Cited Works
- → Osteopetrosis in mice lacking NF-κB1 and NF-κB2(1997)992 cited
- → Defects in Macrophage Recruitment and Host Defense in Mice Lacking the CCR2 Chemokine Receptor(1997)710 cited
- → Impaired Macrophage Function and Enhanced T Cell-Dependent Immune Response in Mice Lacking CCR5, the Mouse Homologue of the Major HIV-1 Coreceptor(1998)248 cited
- → Dynamics of β-Amyloid Reductions in Brain, Cerebrospinal Fluid, and Plasma of β-Amyloid Precursor Protein Transgenic Mice Treated with a γ-Secretase Inhibitor(2005)159 cited
- → Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes.(1996)159 cited
- → Regulation of Inflammatory Responses by Oncostatin M(1999)114 cited
- Regulation of inflammatory responses by oncostatin M.(1999)
- → The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection(2014)110 cited
- → Antigen-Induced Eosinophilic Lung Inflammation Develops in Mice Deficient in Chemokine Eotaxin(1998)93 cited
- → Quantitative Analyses and Transcriptomic Profiling of Circulating Messenger Rnas As Biomarkers of Rat Liver Injury(2010)79 cited